Anlotinib combined with Sintilimab is win-win cooperation for primary squamous cell carcinoma of the thyroid: A case report and literature review

BACKGROUND: Primary squamous cell carcinoma of the thyroid (PSCCT) is a rare malignant tumor. The incidence rate of PSCCT is less than 1%. However, the diagnosis and treatment of PSCCT are limited. Surgical resection is considered to be one of the few effective intervention methods. In this article,...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Zichang, Yu, Maosheng, Zhao, Feng, Zhu, Chenfang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062477/
https://www.ncbi.nlm.nih.gov/pubmed/37007162
http://dx.doi.org/10.3389/fonc.2023.976415

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10062477/
https://www.ncbi.nlm.nih.gov/pubmed/37007162
http://dx.doi.org/10.3389/fonc.2023.976415

Ejemplares similares